Nuveen
TMDX icon

Nuveen’s Transmedics TMDX Stock Holding History

Nuveen’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
79,310
+891
+1% +$75.4K ﹤0.01% 2065
2026
Q1 		$7.8M Buy
78,419
+3,256
+4% +$425K ﹤0.01% 1689
2025
Q4 		$9.14M Sell
75,163
-1,203
-2% -$151K ﹤0.01% 1604
2025
Q3 		$8.57M Sell
76,366
-950
-1% -$111K ﹤0.01% 1637
2025
Q2 		$10.4M Sell
77,316
-10,780
-12% -$1.18M ﹤0.01% 1485
2025
Q1 		$5.93M Buy
88,096
+963
+1% +$66.2K ﹤0.01% 1834
2024
Q4 		$5.43M Sell
87,133
-98,195
-53% -$9.14M ﹤0.01% 1946
2024
Q3 		$29.1M Buy
185,328
+21,001
+13% +$3.24M 0.01% 945
2024
Q2 		$24.8M Buy
164,327
+79,967
+95% +$9.59M 0.01% 993
2024
Q1 		$6.24M Sell
84,360
-2,189
-3% -$180K ﹤0.01% 1861
2023
Q4 		$6.83M Buy
86,549
+1,946
+2% +$117K ﹤0.01% 1799
2023
Q3 		$4.63M Sell
84,603
-514
-0.6% -$37K ﹤0.01% 1903
2023
Q2 		$7.15M Buy
85,117
+2,195
+3% +$168K ﹤0.01% 1711
2023
Q1 		$6.28M Sell
82,922
-12,270
-13% -$849K ﹤0.01% 1758
2022
Q4 		$5.88M Sell
95,192
-18,687
-16% -$993K ﹤0.01% 1821
2022
Q3 		$4.75M Sell
113,879
-8,971
-7% -$390K ﹤0.01% 1935
2022
Q2 		$3.86M Buy
122,850
+16,524
+16% +$441K ﹤0.01% 2117
2022
Q1 		$2.46M Sell
106,326
-35,185
-25% -$630K ﹤0.01% 2405
2021
Q4 		$2.71M Sell
141,511
-912
-0.6% -$22.9K ﹤0.01% 2414
2021
Q3 		$4.71M Buy
142,423
+20,465
+17% +$625K ﹤0.01% 2250
2021
Q2 		$4.05M Sell
121,958
-55,751
-31% -$1.55M ﹤0.01% 2351
2021
Q1 		$7.37M Buy
177,709
+83,489
+89% +$2.57M ﹤0.01% 1960
2020
Q4 		$1.88M Sell
94,220
-663
-0.7% -$9.81K ﹤0.01% 2546
2020
Q3 		$1.31M Buy
94,883
+21,069
+29% +$361K ﹤0.01% 2570
2020
Q2 		$1.32M Buy
73,814
+31,583
+75% +$494K ﹤0.01% 2504
2020
Q1 		$510K Buy
42,231
+44
+0.1% +$737 ﹤0.01% 2765
2019
Q4 		$802K Buy
42,187
+32,416
+332% +$595K ﹤0.01% 2764
2019
Q3 		$232K Hold
9,771
– – ﹤0.01% 3094
2019
Q2 		$283K Buy
+9,771
New +$267K ﹤0.01% 3123

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Nuveen's TMDX Position: Q2 2026 in Review

Nuveen increased its Transmedics (TMDX) stake by 1.1% in Q2 2026, buying an estimated $75.4K and bringing the position to 79,310 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Nuveen first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $29.1M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Nuveen held 79,310 shares of Transmedics worth $5.27M as of Q2 2026.
  • Nuveen bought 891 Transmedics shares in Q2 2026, an estimated $75.4K.
  • Transmedics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2065 holding.
  • Nuveen first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Transmedics position peaked at $29.1M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.